PDL BIOPHARMA INC shareholder history

Current and past PDL BIOPHARMA INC shareholders
Period Weighting Quarter
CompanyLongestShortestMin.Avg.Max.FirstLatest↓ Count
SMH CAPITAL ADVISORS INC 1120.10%18.70%25.84%Q4 2017Q3 202113
WOLVERINE ASSET MANAGEMENT LLC 13130.02%0.18%0.26%Q4 2016Q4 201913
WELLS FARGO & COMPANY/MN 13130.00%0.00%0.00%Q2 2017Q2 202013
LINDEN ADVISORS LP 12120.13%0.48%0.89%Q4 2016Q3 201912
Context Capital Management, LLC 12120.38%5.46%7.67%Q4 2016Q3 201912
LAZARD ASSET MANAGEMENT LLC 11110.01%0.02%0.03%Q4 2016Q2 201911
DEUTSCHE BANK AG\ 11110.00%0.00%0.01%Q4 2016Q2 201911
Citadel Advisors 11110.01%0.01%0.02%Q4 2016Q2 201911
WHITEBOX ADVISORS LLC 11110.39%0.68%0.91%Q4 2016Q2 201911
Pinnacle Holdings, LLC 10100.52%1.05%1.39%Q2 2018Q3 202010
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 820.00%0.00%0.00%Q3 2018Q3 202110
OAKTREE CAPITAL MANAGEMENT LP 990.02%0.07%0.12%Q2 2017Q2 20199
UNITED CAPITAL FINANCIAL ADVISORS, LLC 620.00%0.00%0.02%Q2 2019Q3 20218
AQR Arbitrage LLC 880.04%0.05%0.06%Q4 2016Q3 20188
MORGAN STANLEY 430.00%0.00%0.00%Q1 2018Q4 20197
ENVESTNET ASSET MANAGEMENT INC 770.00%0.00%0.00%Q4 2018Q2 20207
SSI INVESTMENT MANAGEMENT LLC 660.04%0.07%0.09%Q4 2016Q1 20186
ZAZOVE ASSOCIATES LLC 660.03%0.30%0.46%Q4 2016Q1 20186
Independent Advisor Alliance 660.00%0.00%0.01%Q3 2017Q4 20186
Russell Investments Group, Ltd. 330.00%0.00%0.00%Q3 2017Q2 20196
SANDERS MORRIS HARRIS LLC 420.00%0.00%0.01%Q2 2019Q3 20216
Man Investments (CH) AG 550.27%1.56%2.62%Q4 2016Q4 20175
SG Americas Securities, LLC 440.10%0.12%0.15%Q4 2018Q3 20194
ROYAL BANK OF CANADA 310.00%0.00%0.00%Q4 2017Q1 20194
KENNEDY CAPITAL MANAGEMENT LLC 440.02%0.02%0.03%Q2 2018Q1 20194
Advisor Group, Inc. 440.00%0.00%0.00%Q1 2019Q4 20194
BNP PARIBAS FINANCIAL MARKETS 440.00%0.00%0.00%Q3 2018Q2 20194
THRIVENT FINANCIAL FOR LUTHERANS 330.01%0.01%0.01%Q1 2019Q3 20193
Venator Capital Management Ltd. 330.98%1.53%2.35%Q2 2018Q4 20183
Kissinger Financial Services LLC 330.74%0.77%0.79%Q4 2016Q2 20173
BlueCrest Capital Management Ltd 330.03%0.03%0.04%Q3 2017Q1 20183
CREDIT SUISSE AG/ 220.00%0.00%0.00%Q2 2017Q3 20172
WESTWOOD HOLDINGS GROUP INC 110.00%0.01%0.02%Q4 2016Q2 20192
Telemetry Investments, L.L.C. 221.36%1.46%1.56%Q4 2016Q1 20172
OSAIC HOLDINGS, INC. 220.00%0.00%0.00%Q1 2020Q2 20202
XTX Topco Ltd 220.00%0.01%0.02%Q2 2021Q3 20212
MOORE CAPITAL MANAGEMENT, LP 220.04%0.04%0.04%Q4 2016Q1 20172
BANK OF AMERICA CORP /DE/ 220.00%0.00%0.00%Q2 2018Q3 20182
Parallel Advisors, LLC 220.00%0.00%0.00%Q3 2017Q4 20172
Park West Asset Management LLC 221.02%1.20%1.38%Q4 2016Q1 20172
HighTower Advisors, LLC 110.00%0.00%0.00%Q1 2017Q1 20171
Catalyst Capital Advisors LLC 110.12%0.12%0.12%Q2 2017Q2 20171
Arkos Global Advisors 110.02%0.02%0.02%Q2 2020Q2 20201
Soros Fund Management 110.23%0.23%0.23%Q3 2019Q3 20191
Myriad Asset Management Ltd. 110.19%0.19%0.19%Q4 2017Q4 20171
Context Partners Fund, L.P. 114.09%4.09%4.09%Q3 2018Q3 20181
Man Group plc 110.00%0.00%0.00%Q1 2018Q1 20181

This page lists all the filers that currently own PDL BIOPHARMA INC or have owned PDL BIOPHARMA INC in the past.